Ambrx Biopharma Inc. (AMAM)

AI Score

Unlock

28.00

0.02 (0.07%)

At close: Mar 06, 2024, 9:00 PM

Ambrx Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020
Cash & Equivalents	225.26M	228.26M	149.58M	55.61M	55.61M	65.64M	170.06M	167.2M	90.46M
Short-Term Investments	n/a	6.82M	7.94M	28.87M	28.87M	45.25M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	8.8M	16.79M	16.79M	18.83M	n/a	n/a	n/a
Other Long-Term Assets	336K	357K	380K	339K	-56.05M	466K	530K	402K	624K
Receivables	2.36M	2.31M	2.32M	2.05M	376K	2.24M	1.34M	888K	982K
Inventory	5.39M	3.03M	2.86M	3.73M	1.00	6.89M	5.17M	4.68M	1.44M
Other Current Assets	805K	981K	238K	319K	5.72M	986K	230K	261K	191K
Total Current Assets	233.82M	241.41M	162.94M	90.58M	90.58M	121.01M	176.81M	173.03M	93.08M
Property-Plant & Equipment	12.57M	13.24M	13.4M	14.01M	14.01M	15.01M	15.72M	2.96M	3.49M
Goodwill & Intangibles	24.78M	24.93M	25.09M	25.25M	25.25M	25.57M	35.96M	37.34M	36.83M
Total Long-Term Assets	37.68M	38.53M	47.67M	56.39M	56.05M	59.86M	52.21M	40.7M	40.94M
Total Assets	271.5M	279.94M	210.61M	146.98M	146.98M	180.87M	229.02M	213.72M	134.02M
Account Payables	5.14M	6.36M	7.11M	3.21M	3.21M	5.7M	5.27M	3.77M	2.82M
Deferred Revenue	407K	407K	407K	407K	n/a	3.14M	4.27M	4.31M	6.47M
Short-Term Debt	1.92M	1.85M	1.79M	1.73M	n/a	1.32M	915K	1.67M	1.59M
Other Current Liabilities	10.8M	9.56M	6.78M	11.31M	13.46M	15.59M	14.13M	7.73M	2.38M
Total Current Liabilities	18.27M	18.18M	16.09M	16.66M	16.66M	25.74M	24.58M	17.48M	13.26M
Long-Term Debt	8.61M	9.16M	9.71M	10.24M	n/a	11.25M	12.21M	740K	1.6M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	67K	253.17M
Total Long-Term Liabilities	10.83M	11.38M	11.93M	12.47M	n/a	13.24M	14.47M	3.44M	258.91M
Total Liabilities	29.1M	29.56M	28.02M	29.13M	29.13M	38.98M	39.05M	20.93M	272.17M
Total Debt	10.52M	11.02M	11.5M	11.98M	n/a	12.57M	13.13M	2.41M	3.19M
Common Stock	6K	43K	39K	27K	27K	27K	27K	24K	n/a
Retained Earnings	-347.75M	-324.76M	-306.93M	-291.63M	-291.63M	-265.12M	-213.63M	-174.56M	-145.55M
Comprehensive Income	-790K	-953K	-976K	-1.3M	n/a	-1.01M	-790K	-790K	-686K
Shareholders Equity	242.4M	250.38M	182.59M	117.85M	117.85M	141.89M	189.97M	192.8M	-139.43M
Total Investments	n/a	6.82M	7.94M	45.67M	45.67M	64.08M	n/a	n/a	n/a